218 related articles for article (PubMed ID: 32682377)
1. Proteomics Profiling of Plasma Exosomes in VKH Patients.
Zheng H; Yang F; Ea V; Zhou L; Wu L; Zhao G; Shao X; Jiang Y; Huang Y; Li X; Zhang X
Curr Mol Med; 2021; 21(8):675-689. PubMed ID: 32682377
[TBL] [Abstract][Full Text] [Related]
2. Proteomic profiling of aqueous humor-derived exosomes in Vogt-Koyanagi-Harada disease and Behcet's uveitis.
Zhang Y; Deng Y; Jing S; Su G; Li N; Huang Z; Zhang W; Chen Z; Yang P
Clin Immunol; 2024 Feb; 259():109895. PubMed ID: 38185270
[TBL] [Abstract][Full Text] [Related]
3. Vogt-koyanagi-harada syndrome.
Fang W; Yang P
Curr Eye Res; 2008 Jul; 33(7):517-23. PubMed ID: 18600484
[TBL] [Abstract][Full Text] [Related]
4. Vogt-Koyanagi-Harada disease: inquiry into the genesis of a disease name in the historical context of Switzerland and Japan.
Herbort CP; Mochizuki M
Int Ophthalmol; 2007; 27(2-3):67-79. PubMed ID: 17468832
[TBL] [Abstract][Full Text] [Related]
5. Increased serum level of interleukin-33 in Vogt-Koyanagi-Harada correlates with disease activity.
Qian Y; Yu R; Zhao C; Gao F; Zhang M
Clin Immunol; 2021 Oct; 231():108846. PubMed ID: 34478883
[TBL] [Abstract][Full Text] [Related]
6. New insights into Vogt-Koyanagi-Harada disease.
Damico FM; Bezerra FT; Silva GC; Gasparin F; Yamamoto JH
Arq Bras Oftalmol; 2009; 72(3):413-20. PubMed ID: 19668980
[TBL] [Abstract][Full Text] [Related]
7. Different MicroRNA profiles in Peripheral Blood mononuclear cells from patients with initial-onset and recurrent vogt-Koyanagi-Harada Disease.
Guo K; Li B; Yang F; Zhang M; Zhao G; Zhang X
Mol Biol Rep; 2022 Dec; 49(12):11421-11431. PubMed ID: 35988105
[TBL] [Abstract][Full Text] [Related]
8. Integrated omics analysis of sweat reveals an aberrant amino acid metabolism pathway in Vogt-Koyanagi-Harada disease.
Cui X; Su G; Zhang L; Yi S; Cao Q; Zhou C; Kijlstra A; Yang P
Clin Exp Immunol; 2020 Jun; 200(3):250-259. PubMed ID: 32222072
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of proinflammatory cytokine by IL-25 in Vogt-Koyanagi-Harada syndrome.
Xu M; Wang C; Tian Y; Kijlstra A; Yang P
Ocul Immunol Inflamm; 2014 Aug; 22(4):294-9. PubMed ID: 24329541
[TBL] [Abstract][Full Text] [Related]
10. Gut microbial signatures and their functions in Behcet's uveitis and Vogt-Koyanagi-Harada disease.
Wang Q; Wu S; Ye X; Tan S; Huang F; Su G; Kijlstra A; Yang P
J Autoimmun; 2023 May; 137():103055. PubMed ID: 37208257
[TBL] [Abstract][Full Text] [Related]
11. Plasma metabolomics study of Vogt-Koyanagi-Harada disease identifies potential diagnostic biomarkers.
Chen L; Chang R; Pan S; Xu J; Cao Q; Su G; Zhou C; Kijlstra A; Yang P
Exp Eye Res; 2020 Jul; 196():108070. PubMed ID: 32439397
[TBL] [Abstract][Full Text] [Related]
12. Applicability of the 2001 revised diagnostic criteria in Brazilian Vogt-Koyanagi-Harada disease patients.
Cardoso IH; Zajdenweber ME; Muccioli C; Fimamor LP; Belfort R
Arq Bras Oftalmol; 2008; 71(1):67-70. PubMed ID: 18408841
[TBL] [Abstract][Full Text] [Related]
13. Humoral immune response directed against LEDGF in patients with VKH.
Yamada K; Senju S; Shinohara T; Nakatsura T; Murata Y; Ishihara M; Nakamura S; Ohno S; Negi A; Nishimura Y
Immunol Lett; 2001 Oct; 78(3):161-8. PubMed ID: 11578690
[TBL] [Abstract][Full Text] [Related]
14. Vogt-Koyanagi-Harada disease.
O'Keefe GA; Rao NA
Surv Ophthalmol; 2017; 62(1):1-25. PubMed ID: 27241814
[TBL] [Abstract][Full Text] [Related]
15. Association of HLA antigens with Vogt-Koyanagi-Harada syndrome in a Han Chinese population.
Zhao M; Jiang Y; Abrahams IW
Arch Ophthalmol; 1991 Mar; 109(3):368-70. PubMed ID: 2003797
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive profiling of extracellular vesicles in uveitis and scleritis enables biomarker discovery and mechanism exploration.
Wu L; Zhou L; An J; Shao X; Zhang H; Wang C; Zhao G; Chen S; Cui X; Zhang X; Yang F; Li X; Zhang X
J Transl Med; 2023 Jun; 21(1):388. PubMed ID: 37322475
[TBL] [Abstract][Full Text] [Related]
17. Identification of immune hub genes participating in the pathogenesis and progression of Vogt-Koyanagi-Harada disease.
Wang Y; Ju Y; Wang J; Sun N; Tang Z; Gao H; Gu P; Ji J
Front Immunol; 2022; 13():936707. PubMed ID: 35958546
[TBL] [Abstract][Full Text] [Related]
18. Depigmented atrophic lesions in sunset glow fundi of Vogt-Koyanagi-Harada disease.
Inomata H; Rao NA
Am J Ophthalmol; 2001 May; 131(5):607-14. PubMed ID: 11336935
[TBL] [Abstract][Full Text] [Related]
19. [Expression of suppressor of cytokine signaling in peripheral blood monocular cells of patients with Vogt-Koyanagi-Harada disease].
Liu YX; Wang H; Peng XY; Zhou ZC
Zhonghua Yan Ke Za Zhi; 2009 Nov; 45(11):1015-9. PubMed ID: 20137421
[TBL] [Abstract][Full Text] [Related]
20. Leptin increases in Vogt-Koyanagi-Harada (VKH) disease and promotes cell proliferation and inflammatory cytokine secretion.
Liu L; Yang P; He H; Lin X; Jiang L; Chi W; Zhao C; Zhou H
Br J Ophthalmol; 2008 Apr; 92(4):557-61. PubMed ID: 18245271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
